心房内圧センサーインプラントの世界市場：2024年～2031年

概要

心房内圧センサーインプラントの世界市場は、2023年に1,250万米ドルに達し、2031年には1,940万米ドルに達すると予測され、予測期間2024年～2031年のCAGRは5.8%で成長する見込みです。

心房内圧センサーインプラントは、心臓の圧力をモニターし、体液の蓄積や心臓機能の悪化に関するデータをリアルタイムで提供する医療機器です。これらの生体適合デバイスは、カテーテルや外科的処置によって心房に埋め込まれ、正確な治療調整を可能にし、入院を予防し、患者の転帰を改善します。収集されたデータはしばしばヘルスケアプロバイダーにワイヤレスで送信され、タイムリーな介入と心不全のより良い管理を可能にします。

市場力学：

促進要因と抑制要因

心不全有病率の上昇

心不全の世界の有病率の増加は、心房内圧センサーインプラントのような革新的なモニタリングソリューションの需要を促進しています。心不全は数百万人に影響を及ぼし、高い罹患率と死亡率に関連しています。ヘルスケア・システムは、この状態をよりよく管理・監視するための先進技術を求めています。心房圧センサー・インプラントは、症状の悪化を検出するのに役立つリアルタイムのデータを提供し、タイムリーな介入と治療計画の調整を可能にします。

例えば、米国心不全学会によると、心不全は米国で流行している問題であり、20歳以上の米国人約650万人が罹患し、心臓病による死亡者全体の8.5％を占めています。心臓病治療の進歩にもかかわらず、この問題は拡大し続けており、毎年96万人が新たに心不全を発症しています。心不全は主要な殺人者であり、医療の改善が急務であることを浮き彫りにしています。

デバイスに関連する高コスト

心房内圧センサーインプラント市場は、高コスト、製造経費、感染症、デバイスの誤作動、患者の不快感などの潜在的合併症など、いくつかの課題に直面しています。ヘルスケア予算はこうした高コストのために逼迫しており、規制上のハードルや臨床試験は新技術のイントロダクションを遅らせる可能性があります。

さらに、心房圧センサーの利点や機能性に関する医療従事者や患者の認識不足は、その採用を妨げる可能性があります。これらの要因は総体的に心房内圧センサーインプラント市場の成長と拡大に課題となっています。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

• 影響要因
  • 促進要因
    • 心不全有病率の上昇
    • デバイスの進歩
  • 抑制要因
    • デバイスに関連する高コスト
  • 機会
  • 影響分析

第5章 産業分析

• ポーターのファイブフォース分析
• サプライチェーン分析
• 価格分析
• 規制分析
• 特許分析
• PESTLE分析
• SWOT分析
• DMIオピニオン

第6章 製品タイプ別

• 埋め込み型センサー
• 体外式センサー

第7章 アプリケーション別

• 心不全管理
• 不整脈検出
• 術後モニタリング
• その他

第8章 技術別

• 圧力センシング技術
• 遠隔モニタリング技術

第9章 エンドユーザー別

• 病院
• 心臓センター
• 在宅医療
• その他

第10章 地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • その他欧州
• 南米
  • ブラジル
  • アルゼンチン
  • その他南米
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• 中東・アフリカ

第11章 競合情勢

• 競合シナリオ
• 市況/シェア分析
• M&A分析

第12章 企業プロファイル

• Vectorious
  • 会社概要
  • 製品ポートフォリオと説明
  • 財務概要
  • 主な発展
• Medtronic
• Boston Scientific
• Abbott Laboratories
• Cardiac Insight
• Biotronik
• Terumo Corporation

第13章 付録

Overview

Global Atrial Pressure Sensor Implants Market reached US$ 12.5 million in 2023 and is expected to reach US$ 19.4 million by 2031, growing at a CAGR of 5.8% during the forecast period 2024-2031.

Atrial pressure sensor implants are medical devices that monitor heart pressure, providing real-time data on fluid buildup or worsening heart function. These biocompatible devices, implanted in the atrium through catheter or surgical procedures, enable precise treatment adjustments, prevent hospitalizations, and improve patient outcomes. The collected data is often transmitted wirelessly to healthcare providers, enabling timely interventions and better management of heart failure.

Market Dynamics: Drivers & Restraints

Rise in the prevalence of heart failures

The increasing prevalence of heart failure worldwide is driving the demand for innovative monitoring solutions like atrial pressure sensor implants. Heart failure affects millions and is associated with high morbidity and mortality rates. Healthcare systems are seeking advanced technologies to better manage and monitor the condition. Atrial pressure sensor implants provide real-time data that can help detect worsening symptoms, allowing for timely interventions and adjustments to treatment plans.

For instance, according to the Heart Failure Society of America, heart failure is a prevalent issue in the United States, affecting nearly 6.5 million Americans over 20 and accounting for 8.5% of all heart disease deaths. Despite advancements in heart disease treatment, the problem continues to grow, with 960,000 new cases annually. Heart failure is a major killer, highlighting the urgent need for improved health care.

High costs associated with the devices

The atrial pressure sensor implant market faces several challenges, including high costs, manufacturing expenses, and potential complications like infection, device malfunction, and patient discomfort. Healthcare budgets are straining due to these high costs, and regulatory hurdles and clinical trials can delay the introduction of new technologies.

Additionally, lack of awareness among healthcare providers and patients about the benefits and functionalities of atrial pressure sensors may hinder their adoption. These factors collectively pose challenges to the growth and expansion of the atrial pressure sensor implant market.

Segment Analysis

The global atrial pressure sensor implants market is segmented based on product type, application, technology, end-user, and region.

The implantable sensors from the product type segment accounted for approximately 54.1% of the atrial pressure sensor implants market share

The implantable sensors from the product type segment accounted for approximately 54.1%. Implantable sensors in atrial pressure sensor implants are crucial for monitoring heart pressure in real-time, aiding in managing conditions like heart failure. They provide precise measurements, enabling clinicians to track disease progression, adjust treatment plans, and detect early signs of worsening symptoms. This continuous monitoring enhances patient care, enabling timely interventions and improved management of heart conditions.

Geographical Analysis

North America is estimated to hold about 38.4% of the total market share throughout the forecast period

North America is estimated to hold about 38.4% of the total market share throughout the forecast period owing to factors like novel product launches, FDA approvals, expansions, increased healthcare infrastructure, and others that help the region to grow during the forecast period.

For instance, in June 2024, Tel Aviv-based startup Vectorious developed a pressure sensor implanted directly into the heart, allowing chronic heart failure patients to monitor their condition and treat it independently with a physician-approved response. The sensor measures the pressure in the left atrium, one of the heart's two upper chambers, and can identify increases caused by fluid buildup.

Market Segmentation

By Product Type

• Implantable Sensors
• External Sensors

By Application

• Heart Failure Management
• Arrhythmia Detection
• Post-Surgical Monitoring
• Others

By Technology

• Pressure Sensing Technology
• Remote Monitoring Technology

By End-User

• Hospitals
• Cardiac Centers
• Home Care Settings
• Others

By Region

• North America
  • The U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Asia-Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Middle East and Africa

Competitive Landscape

The major global players in the market include Vectorious, Medtronic, Boston Scientific, Abbott Laboratories, Cardiac Insight, Biotronik, and Terumo Corporation among others.

Key Developments

• In July 2024, Vectorious Medical Technologies Ltd. developed a miniature pressure sensor that is implanted within the heart via standard minimally invasive transvenous catheterization. The sensor measures Left Atrial Pressure (LAP), the earliest and most accurate indicator of fluid overload and congestion status. The system supports a scalable, physician-directed patient self-management approach, allowing heart failure (HF) patients to take an active role in managing their disease.

Why Purchase the Report?

• To visualize the global atrial pressure sensor implants market segmentation based on product type, application, technology, end user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of the atrial pressure sensor implants market level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.

The global atrial pressure sensor implants market report would provide approximately 64 tables, 61 figures, and 186 pages.

Target Audience 2023

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

• 3.1. Snippet by Product Type
• 3.2. Snippet by Application
• 3.3. Snippet by Technology
• 3.4. Snippet by End User
• 3.5. Snippet by Region

4. Dynamics

• 4.1. Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. Rise in the prevalence of heart failure
    • 4.1.1.2. Advancements in the devices
  • 4.1.2. Restraints
    • 4.1.2.1. High costs associated with the devices
  • 4.1.3. Opportunity
  • 4.1.4. Impact Analysis

5. Industry Analysis

• 5.1. Porter's Five Force Analysis
• 5.2. Supply Chain Analysis
• 5.3. Pricing Analysis
• 5.4. Regulatory Analysis
• 5.5. Patent Analysis
• 5.6. PESTLE Analysis
• 5.7. SWOT Analysis
• 5.8. DMI Opinion

6. By Product Type

• 6.1. Introduction
  • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 6.1.2. Market Attractiveness Index, By Product Type
• 6.2. Implantable Sensors*
  • 6.2.1. Introduction
• 6.3. External Sensors

7. By Application

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
• 7.2. Market Attractiveness Index, By Application
• 7.3. Heart Failure Management*
  • 7.3.1. Introduction
  • 7.3.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 7.4. Arrhythmia Detection
• 7.5. Post-Surgical Monitoring
• 7.6. Others

8. By Technology

• 8.1. Introduction
  • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
• 8.2. Market Attractiveness Index, By Technology
• 8.3. Pressure Sensing Technology*
  • 8.3.1. Introduction
  • 8.3.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 8.4. Remote Monitoring Technology

9. By End User

• 9.1. Introduction
  • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 9.1.2. Market Attractiveness Index, By End User
• 9.2. Hospitals*
  • 9.2.1. Introduction
  • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 9.3. Cardiac Centers
• 9.4. Home Care Settings
• 9.5. Others

10. By Region

• 10.1. Introduction
  • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  • 10.1.2. Market Attractiveness Index, By Region
• 10.2. North America
  • 10.2.1. Introduction
  • 10.2.2. Key Region-Specific Dynamics
  • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.2.7.1. The U.S.
    • 10.2.7.2. Canada
    • 10.2.7.3. Mexico
• 10.3. Europe
  • 10.3.1. Introduction
  • 10.3.2. Key Region-Specific Dynamics
  • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.3.7.1. Germany
    • 10.3.7.2. UK
    • 10.3.7.3. France
    • 10.3.7.4. Italy
    • 10.3.7.5. Spain
    • 10.3.7.6. Rest of Europe
• 10.4. South America
  • 10.4.1. Introduction
  • 10.4.2. Key Region-Specific Dynamics
  • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.4.7.1. Brazil
    • 10.4.7.2. Argentina
    • 10.4.7.3. Rest of South America
• 10.5. Asia-Pacific
  • 10.5.1. Introduction
  • 10.5.2. Key Region-Specific Dynamics
  • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.5.7.1. China
    • 10.5.7.2. India
    • 10.5.7.3. Japan
    • 10.5.7.4. South Korea
    • 10.5.7.5. Rest of Asia-Pacific
• 10.6. Middle East and Africa
  • 10.6.1. Introduction
  • 10.6.2. Key Region-Specific Dynamics
  • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

• 11.1. Competitive Scenario
• 11.2. Market Positioning/Share Analysis
• 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

• 12.1. Vectorious*
  • 12.1.1. Company Overview
  • 12.1.2. Product Portfolio and Description
  • 12.1.3. Financial Overview
  • 12.1.4. Key Developments
• 12.2. Medtronic
• 12.3. Boston Scientific
• 12.4. Abbott Laboratories
• 12.5. Cardiac Insight
• 12.6. Biotronik
• 12.7. Terumo Corporation

LIST NOT EXHAUSTIVE

13. Appendix

• 13.1. About Us and Services
• 13.2. Contact Us